PATENT CLAIM ANALYSIS

Application Number: 16046027
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "229500"]

Abstract:
The invention is directed to a method for alleviating respiratory depression in a subject as a result of disease of pharmacological agents such as opiates, opioids or barbiturates. The invention also discloses pharmaceutical compositions for use with the method, the composition containing in combination, an analgesic, anaesthetic, or a sedative and a positive allosteric AMPA receptor modulator in an amount sufficient to reduce or inhibit respiratory depression caused by the analgesic, anaesthetic, or sedative.

Claim (Index 6):
The method of  claim 1 , wherein the positive allosteric AMPA receptor modulator is a benzofurazan compound.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 95.0
- Lexical Diversity: 1.59615
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11847835', '13557681', '09974004', '13348171', '13755210']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7180579659930224
- 35 USC 102 Novelty (BERT): 0.5894090195767112
- Combined Prediction Score: 0.7051930713513913
- Mean Citation Score: 254.5203
- Max Citation Score: 545.872
- Similarity Product: 373.3847531385421

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test